Low-dose rituximab should be used for treating MS in resource-limited settings: Commentary
Mult Scler
.
2022 Jun;28(7):1032-1033.
doi: 10.1177/13524585221098612.
Authors
Claudia Cárcamo
1
,
Ethel Ciampi
2
Affiliations
1
Departamento de Neurología, PontificiaUniversidad Católica de Chile, Santiago, Chile.
2
Departamento de Neurología, Pontificia Universidad Católica de Chile, Santiago, Chile; Servicio de Neurología, Hospital Sótero del Río, Santiago, Chile.
PMID:
35608104
DOI:
10.1177/13524585221098612
No abstract available
Publication types
Comment
MeSH terms
Humans
Immunologic Factors* / therapeutic use
Multiple Sclerosis* / drug therapy
Rituximab / therapeutic use
Substances
Immunologic Factors
Rituximab